-
Mashup Score: 4
Immune checkpoint inhibitors (i.e. anti-PD1, anti-PDL1, and anti-CTLA4) have revolutionized the therapeutic approach of several cancer types. In a sub…
Source: www.sciencedirect.comCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 3Area Soci - AIOM - 3 year(s) ago
L’Associazione ha lo scopo di promuovere il progresso oncologico nel campo clinico, sperimentale e socio-assistenziale, la prevenzione primaria e secondaria, la qualità delle cure oncologiche, la continuità terapeutica del paziente oncologico, Home – AIOM – Associazione Italiana di Oncologia Medica
Source: AiomCategories: Latest Headlines, Oncologists1Tweet-
Aperte fino alle ore 19 di sabato 23/10/2021 le elezioni @AIOMtweet: spero veramente di avere l’opportunità di servire la grande comunità oncologica italiana nel direttivo nazionale con il mio entusiasmo e la mia determinazione! Link: https://t.co/VNYgT769nC, #UNIGEnonsiferma https://t.co/pgpLUIAYCp
-
-
Mashup Score: 0Module - 3 year(s) agoSource: esmocongress.esmo.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Finally it's @myESMO #ESMO21 time!!! Already available online our educational session on management of patients with #metastatic #BreastCancer @OncoAlert @UniGenova @SanMartino_Ge #UNIGEnonsiferma #UNIGE @hoperugo Link: https://t.co/8U7OWYUzKl https://t.co/ltdxAxaICV
-
-
Mashup Score: 1Reproductive issues in carriers of germline pathogenic variants in the BRCA1/2 genes: an expert meeting - BMC Medicine - 3 year(s) ago
Background Healthy individuals and patients with cancer who are carriers of germline pathogenic variants in the BRCA1/2 genes face multiple reproductive challenges that require appropriate counseling and specific expertise. Main body On December 5th–7th, 2019, patient advocates and physicians with expertise in the field of reproductive medicine, fertility preservation, and oncology were invited…
Source: BMC MedicineCategories: Latest Headlines, Oncologists1Tweet-
Finally published in @BMCMedicine our expert meeting providing recommendations on #reproductive issues in #BRCA carriers: hope this can help in the counseling of both healthy women and #BreastCancer patients #UNIGEnonsiferma @OncoAlert #bcsm Link: https://t.co/eHneURzPoz https://t.co/7u3HSSfGLP
-
-
Mashup Score: 4Meeting Library | Meeting Library - 3 year(s) ago
2318 Mill Road, Suite 800, Alexandria, VA 22314 · 571-483-1300 ©2021 American Society of Clinical Oncology (ASCO). All Rights Reserved Worldwide.
Source: meetinglibrary.asco.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Looking forward to #ASCO21: important data by the Italian #BreastCancer group #GIM with the final analysis of #PROMISE-#GIM6 trial on #GnRHa use during #chemotherapy for ovarian function preservation @OncoAlert #UNIGEnonsiferma #bcsm Full abstract here: https://t.co/rEGoQTcrgn https://t.co/5kT9YQH5Wb
-
-
Mashup Score: 0Relationship Between Germline BRCA Pathogenic Variants and Diminished Ovarian Reserve - The ASCO Post - 3 year(s) ago
By Matthew Stenger Posted: 5/7/2021 9:50:00 AM Last Updated: 5/7/2021 10:32:46 AM In a study reported in the Journal of Clinical Oncology, Turan et al found the presence of germline BRCA pathogenic variants was associated with diminished ovarian reserve in young women,…
Source: ascopost.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Our @ASCO_pubs #JCO paper exploring the relationship between carrying germline #BRCA pathogenic variants and diminished ovarian reserve is featured in the @ASCOPost @OncoAlert @UniGenova @SanMartino_Ge #UNIGEnonsiferma #bcsm #oncofertility #AMH https://t.co/gUreIiXJCH
-
-
Mashup Score: 1Association of Germline BRCA Pathogenic Variants With Diminished Ovarian Reserve: A Meta-Analysis of Individual Patient-Level Data - 3 year(s) ago
PURPOSE To determine whether germline BRCA (gBRCA) pathogenic variants are associated with decreased ovarian reserve. MATERIALS AND METHODS An individual patient-level data meta-analysis was performed using five data sets on 828 evaluable women who were tested for gBRCA. Of those, 250 carried gBRCA, whereas 578 had tested negative and served as controls. Of the women with gBRCA, four centers…
Source: Journal of Clinical OncologyCategories: Hem/Oncs, Latest HeadlinesTweet-
Important international collaboration out in @ASCO_pubs #JCO to improve the #oncofertility counseling of young #BRCA carriers with #BreastCancer: proud of this work with #Oktay team after our prior #SABCS17 "fight" @OncoAlert #bcsm #UNIGEnonsiferma @ASCO https://t.co/i1A8uv0oBl
-
-
Mashup Score: 13How I perform fertility preservation in breast cancer patients - 3 year(s) ago
IntroductionAdditional age-related issues should be considered when managing breast cancer in young women.1 Among them, the potential consequences of anticancer treatments on ovarian function and fertility potential are of particular concern and need to be addressed as early as possible after diagnosis.2,3 Therefore, current guidelines strongly voice the need to provide proper oncofertility…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Super @MRazeti from @UniGenova @SanMartino_Ge for this clear brief overview in @ESMO_Open on how to perform #oncofertility counseling in #BreastCancer patients: proud of my great fellows! @OncoAlert @myESMO #bcsm #DreamTeam #UNIGEnonsiferma @maclaudiaa https://t.co/qwnRsZNGQ1
-
-
Mashup Score: 2
Expert: Matteo Lambertini, San Martino Hospital, Genoa, Italy
Source: www.e-eso.netCategories: Hem/Oncs, Latest HeadlinesTweet-
Looking forward to seeing you tomorrow March 22 at 6:15 pm CET for the #e_ESO session on ovarian function suppression in premenopausal women with early #BreastCancer ! @ESOncology @OncoAlert @SanMartino_Ge @UniGenova #UNIGEnonsiferma #ESO #bcsm #BCY https://t.co/wX1PQfvN7T https://t.co/NiAgurlZRR
-
-
Mashup Score: 0Body Mass Index and Weight Change in Patients With HER2-Positive Early Breast Cancer: Exploratory Analysis of the ALTTO BIG 2-06 Trial - 3 year(s) ago
Background: The association between obesity and prognosis in HER2-positive early breast cancer remains unclear, with limited data available. This study aimed to determine the impact of body mass index (BMI) at baseline and weight change after 2 years on outcomes of patients with HER2-positive early breast cancer. Methods: ALTTO was a…
Source: JNCCNCategories: Hem/Oncs, Latest HeadlinesTweet-
Just out in @JNCCN our exploratory analysis of the @BIGagainstBC ALTTO trial showing the prognostic impact of #BMI and weight change in #HER2+ early #BreastCancer patients: great work @SamuelMartel87 @E_de_Azambuja et al! #UNIGEnonsiferma @OncoAlert #bcsm https://t.co/WmBHLlIxz4
-
Out in @ESMO_Open our review led by @puglisi_fabio's group on impact of #checkpoint inhibitors on #fertility #pregnancy and #SexualHealth: we need to do more considering the limited evidence despite the wide #immunotherapy use @OncoAlert #UNIGEnonsiferma https://t.co/g9592V1HA9 https://t.co/dtdx0Rt4fp